In a time of increasingly bespoke healthcare, Elizabeth Philp has emerged as a formidable figure of innovation, notably in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the helm of a drive to make bespoke medications more obtainable, questioning the traditional one-size-fits-all